Drugs & Targets Fuse Oncology, University of Michigan form radiation oncology collaboration December 15, 2023Vol.49 No.46
News Analysis Dana-Farber’s bold split from the Brigham is a culmination of Boston oncology’s complicated history December 08, 2023Vol.49 No.45By Jacquelyn Cobb
As Bertagnolli steps in, NIH and FDA reenvision clinical trials and evidence generation December 08, 2023Vol.49 No.45By Matthew Bin Han Ong
Guest Editorial New leadership, vision for the Worldwide Innovative Network Consortium in precision oncology December 08, 2023Vol.49 No.45By Wafik S. El-Deiry
Guest Editorial Turning the page: Projections for cancer care in the coming year December 08, 2023Vol.49 No.45By Samyukta Mullangi
Letter To The Editor The field of population epigenetics is failing on rigor and reproducibility December 08, 2023Vol.49 No.45
In Brief Angela Yoon named director of MUSC Hollings Cancer Center Biorepository and Tissue Analysis Shared Resource December 08, 2023Vol.49 No.45
